Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Johnson

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Blood|October 24, 2002
Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group studyJeanne E Anderson, Kenneth J Kopecky, Cheryl L Willman, et al.
Breast Cancer Research and Treatment|February 14, 2009
Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CCStephanie L Hines, Betty Mincey, Todor Dentchev, et al.
Breast Cancer Research and Treatment|June 7, 2020
N083E (Alliance): long-term outcomes of patients treated in a pilot phase II study of docetaxel, carboplatin, trastuzumab, and lapatinib as adjuvant therapy for early-stage HER2-positive breast cancerRoberto A Leon-Ferre, Edith A Perez, David W Hillman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2010
Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trialAmanda R Moraska, Amit Sood, Shaker R Dakhil, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2014
A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321Yujie Zhao, Nathan R Foster, Jeffrey P Meyers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2006
Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5Charles L Loprinzi, John W Kugler, Debra L Barton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2013
Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trialPaul E Goss, James N Ingle, Kathleen I Pritchard, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Blood|October 24, 2002
Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group studyJeanne E Anderson, Kenneth J Kopecky, Cheryl L Willman, et al.
Breast Cancer Research and Treatment|February 14, 2009
Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CCStephanie L Hines, Betty Mincey, Todor Dentchev, et al.
Breast Cancer Research and Treatment|June 7, 2020
N083E (Alliance): long-term outcomes of patients treated in a pilot phase II study of docetaxel, carboplatin, trastuzumab, and lapatinib as adjuvant therapy for early-stage HER2-positive breast cancerRoberto A Leon-Ferre, Edith A Perez, David W Hillman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2010
Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trialAmanda R Moraska, Amit Sood, Shaker R Dakhil, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2014
A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321Yujie Zhao, Nathan R Foster, Jeffrey P Meyers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2006
Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5Charles L Loprinzi, John W Kugler, Debra L Barton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2013
Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trialPaul E Goss, James N Ingle, Kathleen I Pritchard, et al.
Pageof 4